Does below-the-knee placement of drug-eluting stents improve clinical outcomes?

Journal of Cardiovascular Surgery

Volumn 53, Issue 2, 2012, Pages 195-203

  Katsanos, K ^a,b   Spiliopoulos, S ^a   Krokidis, M ^b   Karnabatidis, D ^a   Siablis, D ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Angioplasty; Limb salvage; Stents

Indexed keywords

CYPHER; EVEROLIMUS; EXPRESS; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG;

BARE METAL STENT; BELOW KNEE AMPUTATION; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; HUMAN; MULTICENTER STUDY (TOPIC); PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVIEW; TREATMENT OUTCOME; WOUND HEALING; BLOOD VESSEL PROSTHESIS; ENDOVASCULAR SURGERY; ISCHEMIA; LEG; METHODOLOGY; POPLITEAL ARTERY; PROSTHESIS; VASCULARIZATION;

ANGIOPLASTY, BALLOON; BLOOD VESSEL PROSTHESIS; DRUG-ELUTING STENTS; ENDOVASCULAR PROCEDURES; HUMANS; ISCHEMIA; LEG; POPLITEAL ARTERY; PROSTHESIS DESIGN; TREATMENT OUTCOME;

EID: 84861795383     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5-67.
2. Novo S, Coppola G, Milio G. Critical limb ischemia: definition and natural history. Curr Drug Targets Cardiovasc Haematol Disord 2004;4:219-25. (Pubitemid 39162412)
3. Tsetis D, Belli AM. The role of infrapopliteal angioplasty. Br J Radiol 2004;77:1007-15. (Pubitemid 40057797)
4. Dorros G, Jaff MR, Dorros AM, Mathiak LM, He T. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation 2001;104:2057-62. (Pubitemid 33027046)
5. Bosiers M, Hart JP, Deloose K, Verbist J, Peeters P. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular 2006;14:63-9. (Pubitemid 44047250)
6. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) - summary of recommendations. J Vasc Interv Radiol 2006;17:1383-97; quiz 98.
7. Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues. J Endovasc Ther 2009;16(Suppl 1):1153-62.
8. Duda SH, Poerner TC, Wiesinger B, Rundback JH, Tepe G, Wiskirchen J et al. Drug-eluting stents: potential applications for peripheral arterial occlusive disease. J Vasc Interv Radiol 2003;14:291-301. (Pubitemid 36314757)
9. Ong AT, Serruys PW. Technology Insight: an overview of research in drug-eluting stents. Nat Clin Pract Cardiovasc Med 2005;2:647-58. (Pubitemid 43012602)
10. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol 2004;44:2307-14. (Pubitemid 39647603)
11. Scheinert D, Ulrich M, Scheinert S, Sax J, Braunlich S, Biamino G. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. Eurointervention 2006;2:169-74.
12. Siablis D, Kraniotis P, Karnabatidis D, Kagadis GC, Katsanos K, Tsolakis J. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther 2005;12:685-95. (Pubitemid 43100926)
13. Siablis D, Karnabatidis D, Katsanos K, Kagadis GC, Kraniotis P, Diamantopoulos A et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther 2007;14:241-50. (Pubitemid 46776123)
14. Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008;47:975-81.
15. Kandarpa K, Becker GJ, Hunink MG, McNamara TO, Rundback JH, Trost DW et al. Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: part I. J Vasc Interv Radiol 2001;12:683-95. (Pubitemid 32521156)
16. Conrad MF, Kang J, Cambria RP, Brewster DC, Watkins MT, Kwolek CJ et al. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease. J Vasc Surg 2009;50:799-805 e4.
17. Faries PL, Arora S, Pomposelli FB Jr, Pulling MC, Smakowski P, Rohan DI et al. The use of arm vein in lower-extremity revascularization: results of 520 procedures performed in eight years. J Vasc Surg 2000;31(1 Pt 1):50-9. (Pubitemid 30067302)
18. Ballard JL, Mills JL Sr. Surgical management of critical limb ischemia. Tech Vasc Interv Radiol 2005;8:169-74. (Pubitemid 44038931)
19. Albers M, Romiti M, Brochado-Neto FC, De Luccia N, Pereira CA. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg 2006;43:498-503.
20. Soderstrom MI, Arvela EM, Korhonen M, Halmesmaki KH, Alback AN, Biancari F et al. Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia: a propensity score analysis. Ann Surg 2010;252:765-73.
21. Peregrin JH, Koznar B, Kovac J, Lastovickova J, Novotny J, Vedlich D et al. PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol 2010;33:720-5.
22. Dorros G, Hall P, Prince C. .Successful limb salvage after recanalization of an occluded infrapopliteal artery utilizing a balloon expandable (Palmaz-Schatz) stent. Cathet Cardiovasc Diagn 1993;28:83-8. (Pubitemid 23039025)
23. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Christeas N, Kagadis GC. Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results. J Vasc Interv Radiol 2007;18:1351-61. (Pubitemid 350010920)
24. Commeau P, Barragan P, Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv 2006;68:793-8. (Pubitemid 44721107)
25. Bosiers M, Deloose K, Verbist J, Peeters P. Percutaneous transluminal angioplasty for treatment of "below-the-knee" critical limb ischemia: early outcomes following the use of sirolimus-eluting stents. J Cardiovasc Surg (Torino) 2006;47:171-6.
26. Scheinert D. Update: Drug-eluting stents in tibial arteries. Endovasc Today 2007;8:71-4.
27. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Spiliopoulos S, Kagadis GC et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 2009;20:1141-50.
28. Balzer JO, Zeller T, Rastan A, Sixt S, Vogl TJ, Lehnen T et al. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents. J Cardiovasc Surg (Torino) 2010;51:183-91.
29. Rosales OR, Mathewkutty S, Gnaim C. Drug eluting stents for below the knee lesions in patients with critical limb ischemia: long-term follow-up. Catheter Cardiovasc Interv 2008;72:112-5. (Pubitemid 352008995)
30. Grant AG, White CJ, Collins TJ, Jenkins JS, Reilly JP, Ramee SR. Infrapopliteal drug-eluting stents for chronic limb ischemia. Catheter Cardiovasc Interv 2008;71:108-11. (Pubitemid 351158354)
31. Feiring AJ, Krahn M, Nelson L, Wesolowski A, Eastwood D, Szabo A. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol 2010;55:1580-9.
32. Biondi-Zoccai GG, Sangiorgi G, Lotrionte M, Feiring A, Commeau P, Fusaro M et al. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther 2009;16:251-60.
33. Rastan A, Schwarzwalder U, Noory E, Taieb FH, Beschorner U, Sixt S et al. Primary use of sirolimus-eluting stents in the infrapopliteal arteries. J Endovasc Ther 2010;17:480-7.
34. Palmaz JC. The balloon-expandable stent. Eurointervention 2007;2:416-21.
35. Karnabatidis D, Spiliopoulos S, Diamantopoulos A, Katsanos K, Kagadis GC, Kakkos S et al. Primary everolimus-eluting stent-ing versus balloon angioplasty with bailout bare metal stent-ing of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther 2011;18:1-12.
36. Lookstein R, Ward T, Kim E, Fischman A, Nowakowksi F, Ellozy S et al. Value of drug-eluting stents after failed percutaneous transluminal angioplasty in the infrapopliteal vessels for the treatment of critical limb ischemia: favorable mid-term patency and limb salvage results. J Cardiovasc Surg (Torino) 2011;52:461-6.
37. Werner M, Schmidt A, Freyer M, Bausback Y, Braunlich S, Friedenberger J et al. Sirolimus-Eluting Stents for the Treatment of Infrapopliteal Arteries in Chronic Limb Ischemia: Long-term Clinical and Angiographic Follow-up. J Endovasc Ther 2012;19:12-9.
38. Rastan A, Tepe G, Krankenberg H, Zahorsky R, Beschorner U, Noory E et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. Eur Heart J 2011;32:2274-81.
39. Bosiers M, Scheinert D, Peeters P, Torsello G, Zeller T, Deloose K et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg 2012;55:390-8.
40. Katsanos K, Siablis D, Zeller T, Lammer J, Bosiers M, Commeau P et al. The ACHILLES study, a prospective, randomized, multicenter comparison of balloon angioplasty and CYPHER SELECT® plus stent implantation in the treatment of patients with ischemic infrapopliteal arterial disease. CIRSE annual postgraduate meeting. 2011;Munich: Germany.
41. Karnabatidis D, Katsanos K, Spiliopoulos S, Diamantopoulos A, Kagadis GC, Siablis D. Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon-expandable metal stents. J Endovasc Ther 2009;16:15-22.
42. Kawarada O, Yokoi Y, Higashimori A, Waratani N, Waseda K, Honda Y et al. Stent-assisted below-the-ankle angioplasty for limb salvage. J Endovasc Ther 2011;18:32-42.
43. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006;47:175-81. (Pubitemid 43005183)
44. Katsanos K, Karnabatidis D, Diamantopoulos A, Spiliopoulos S, Siablis D. Cost-effectiveness analysis of infrapopliteal drug-eluting stents. Cardiovasc Intervent Radiol 2012 [In press].
45. Katsanos K, Diamantopoulos A, Siablis D. Commentary: prime time for infrapopliteal drug-eluting stents? J Endovasc Ther 2012;19:20-2.
46. Alexandrescu V, Hubermont G. The challenging topic of diabetic foot revascularization: does the angiosome-guided angioplasty may improve outcome. J Cardiovasc Surg (Torino) 2012;53:3-12.
47. Peeters P, Keirse K, Verbist J, Deloose K, Bosiers M. Are bio-absorbable stents the future of SFA treatment' J Cardiovasc Surg (Torino) 2010;51:121-4.
48. Bosiers M, Peeters P, D'Archambeau O, Hendriks J, Pilger E, Duber C et al. AMS INSIGHT-absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol 2009;32:424-35.
49. Dudek D, Onuma Y, Ormiston JA, Thuesen L, Miquel-Hebert K, Serruys PW. Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention 2012;7:1060-1.
50. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009;373:897-910.